Evidence map›Paper›PMID 34029929›Full record

ArticleClinical imaging2021

Complications in COVID-19 patients: Characteristics of pulmonary embolism.

Riccardo Cau, Alberto Pacielli, Homayounieh Fatemeh, Paolo Vaudano, Chiara Arru, Paola Crivelli, Giuseppe Stranieri, Jasjit S Suri, Lorenzo Mannelli, Maurizio Conti and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Chest CT in COVID-19 patients: A clinical need.Journal of medical radiation sciences · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. COVID-19 pneumonia: lessons learned, challenges, and preparing for the future.Diagnostic and interventional radiology (Ankara, Turkey) · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. COVLIAS 1.0Diagnostics (Basel, Switzerland) · 2022
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Riccardo CauDepartment of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), di Cagliari - Polo di Monserrato s.s. 554, Monserrato (Cagliari) 09045, Italy.
Alberto PacielliDepartment of Radiology, Ospedale S. Giovanni Bosco, 10154 Turin, Italy.
Homayounieh FatemehDepartment of Radiology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, USA.
Paolo VaudanoDepartment of Radiology, Ospedale S. Giovanni Bosco, 10154 Turin, Italy.
Chiara ArruDepartment of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), di Cagliari - Polo di Monserrato s.s. 554, Monserrato (Cagliari) 09045, Italy.
Paola CrivelliDepartment of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), di Sassari - Sassari, Italy.
Giuseppe StranieriDepartment of Radiology, Ospedale S. Giovanni Bosco, 10154 Turin, Italy.
Jasjit S SuriStroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, CA, USA.
Lorenzo MannelliIRCSS SDN, Napoli, Italy.
Maurizio ContiDepartment of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), di Sassari - Sassari, Italy.
Abdelkader MahammediDepartment of Neuroradiology, University of Cincinnati Medical Center, OH 45267, USA.
Mannudeep KalraDepartment of Radiology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, USA.
Luca SabaDepartment of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), di Cagliari - Polo di Monserrato s.s. 554, Monserrato (Cagliari) 09045, Italy. Electronic address: lucasaba@tiscali.it.
Azienda Ospedaliero-Universitaria Cagliari · ITOspedale San Giovanni Bosco · ITAzienda Ospedaliero Universitaria di Sassari · ITMassachusetts General Hospital · USSDN Istituto di Ricerca Diagnostica e Nucleare · ITUniversity of Cincinnati · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe purpose of this study is to evaluate chest CT imaging features, clinical characteristics, laboratory values of COVID-19 patients who underwent CTA for suspected pulmonary embolism. We also examined whether clinical, laboratory or radiological characteristics could be associated with a higher rate of PE. MATERIALS AND

methodsThis retrospective study included 84 consecutive patients with laboratory-confirmed SARS-CoV-2 who underwent CTA for suspected PE. The presence and localization of PE as well as the type and extent of pulmonary opacities on chest CT exams were examined and correlated with the information on comorbidities and laboratory values for all patients.

resultsOf the 84 patients, pulmonary embolism was discovered in 24 patients. We observed that 87% of PE was found to be in lung parenchyma affected by COVID-19 pneumonia. Compared with no-PE patients, PE patients showed an overall greater lung involvement by consolidation (p = 0.02) and GGO (p < 0.01) and a higher level of D-Dimer (p < 0,01). Moreover, the PE group showed a lower level of saturation (p = 0,01) and required more hospitalization (p < 0,01).

conclusionOur study showed a high incidence of PE in COVID-19 pneumonia. In 87% of patients, PE was found in lung parenchyma affected by COVID-19 pneumonia with a worse CT severity score and a greater number of lung lobar involvement compared with non-PE patients. CT severity, lower level of saturation, and a rise in D-dimer levels could be an indication for a CTPA. ADVANCES IN KNOWLEDGE: Certain findings of non-contrast chest CT could be an indication for a CTPA.

Indexed as

COVID-19Pulmonary EmbolismHumansRetrospective StudiesSARS-CoV-2Tomography, X-Ray ComputedCovid-19CTCTPAD-dimerPulmonary embolism

Identifiers

PMID34029929
PMCPMC8130594
OpenAlexW3163027578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.